(Q36842371)

16 August 2017

title

Iloperidone binding to human and rat dopamine and 5-HT receptors (English)

1 reference

16 August 2017

Kongsamut S

1

1 reference

16 August 2017

Roehr JE

2

1 reference

16 August 2017

Cai J

3

1 reference

16 August 2017

Hartman HB

4

1 reference

16 August 2017

Weissensee P

5

1 reference

16 August 2017

Kerman LL

6

1 reference

16 August 2017

Tang L

7

1 reference

16 August 2017

Sandrasagra A

8

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

European Journal of Pharmacology

16 August 2017

published in

1 reference

16 August 2017

volume

317

1 reference

16 August 2017

issue

2-3

1 reference

16 August 2017

page(s)

417-423

1 reference

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Effects of atypical antipsychotic agents on social behavior in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Clozapine-induced weight gain: prevalence and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Seroquel: biochemical profile of a potential atypical antipsychotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900840-0

10.1016/S0014-2999(96)00840-0

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference